Your EHR can help you identify patients appropriate for HCV screening
A clinical decision support (CDS) notification will display in a patient’s chart if the patient has clinical markers indicating HCV screening may be appropriate.
The notification is based on guidelines from the Centers for Disease Control (CDC), U.S. Preventive Services Task Force (USPSTF), and the American Association for the Study of Liver Diseases (AASLD):
HCV screening: Patient has a clinical profile indicating Hepatitis C screening may be appropriate. Consider ordering HCV antibody test with reflexive viral RNA test.
Intervention Developer: Practice Fusion, Inc.
Funding Source: Gilead Sciences, Inc.
Release Version: 1
Reference Information: CDC Testing Recommendations for Hepatitis C Virus Infection Division of Viral Hepatitis and National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention October 15, 2015 https://www.cdc.gov/hepatitis/hcv/guidelinesc.htm. Guidelines for Laboratory Testing and Result Reporting of Hepatitis C Virus https://www.cdc.gov/mmwr/preview/mmwrhtml/rr5203a1.htm. AASLD-IDSA Recommendations for testing, managing, and treating hepatitic C October 2016 Version a. www.hcvguidelines.org
You can adjust the display of CDS notifications for HCV screening at any time from the Notifications and Alerts section of your EHR settings.
An HCV antibody test with reflexive viral RNA test can help you diagnose and confirm active HCV 1-3
The CDC recommends testing for HCV to begin with either a rapid or a laboratory-conducted assay for HCV antibody in blood. A nonreactive result indicates no HCV antibody detected. A reactive result may indicate:
- A current HCV infection
- A past HCV infection
- A false positive
A reactive result should be followed with an HCV RNA test. If HCV RNA is detected, this indicates current HCV infection. If HCV RNA is not detected, it indicates a resolved HCV infection, or false HCV antibody positivity.
- Centers for Disease Control and Prevention. Guidelines for Laboratory Testing and Result Reporting of Antibody to Hepatitis C Virus.
https://www.cdc.gov/mmwr/preview/mmwrhtml/rr5203a1.htm. Updated January 2003. Accessed March 27, 2017.
- Centers for Disease Control and Prevention. Viral hepatitis – hepatitis C information. https://www.cdc.gov/hepatitis/hcv/guidelinesc.htm. Updated October 2015. Accessed March 27, 2017.
- American Association for the Study of liver Diseases, Infectious Diseases Society of America, and International Aids Society USA. Recommendations for testing, managing, and treating hepatitis C. http://www.hcvguidelines.org. Accessed March 27, 2017.